SENSEX 77414.92 ▼ (0.25%)
BSE BANKEX 59542.38 ▲ (0.36%)

MARKSANS PHARMA

BSE: 524404 29 Jun 2025
Healthcare
₹ 240.9
Marksans Pharma Ltd. specializes in Pharmaceuticals within the Healthcare sector.

MARKSANS PHARMA - Share Price & Details

Market Cap
₹10,876
High /Low
359.0 / 158.0
Stock P/E
28.6
Book Value
₹54.4
Dividend Yield
0.25
ROCE
20.1
ROE
₹16.8
Face Value
1.0
PEG Ratio
1.11
EVEBITDA
₹17.5
Debt
322
CMP / FCF
135.0
Debt to equity
₹0.13
NP Ann
383
High price all time
359.0
Piotroski score
₹4.0
Graham Number
101.0
No. Eq. Shares
45.3
Net CF
₹92.5
Net profit
383
Price to book value
4.41
Interest Coverage
₹44.2
Low price all time
1.27
Industry PE
32.0
Reserves
₹2,422
Free Cash Flow
₹35.0

Price Chart


Volume Chart


Peer Comparison

Stock Total Income Net Profit Net Sales EPS Market Cap (in Cr) P/E
LOOKS HEALTH SERVICES LIMITEDNANANANA5.11256.0
Triochem Products Ltd.,NANANANA0
MARKSANS PHARMA LTD.3071.74375.912993.570.8310,87628.6
Vijaya Diagnostic Centre Limit1655.33331.191598.523.221016270.6
PROCTER & GAMBLE HEALTH LIMITENANANANA980537.7

Peer Comparison Chart


About MARKSANS PHARMA

Marksans Pharma Ltd., with Security Code 524404, is a leading player in the Pharmaceuticals industry, categorized under the Healthcare sector, offering Equity instruments.


Latest News

Marksans Pharma's UK arm gets marketing nod for Oxybutynin Oral solution from UKMHRA

(19 Jun 2025)
Marksans Pharma announced that its wholly owned subsidiary Relonchem has received marketing authorization for the product Oxybutynin...
Read more →

Marksans Pharma’s UK arm gets marketing nod for Oxybutynin Oral solution from UKMHRA

(19 Jun 2025)
(19 Jun 2025, 10:04). Marksans Pharma's UK arm gets marketing nod for Oxybutynin Oral solution from UKMHRA. Marksans Pharma announced that its wholly owned...
Read more →

Marksans Pharma arm gets UK drug regulator nod for overactive bladder treatment drug

(19 Jun 2025)
Marksans Pharma Ltd. on Thursday, June 19, said its UK-based subsidiary, Relonchem Ltd, has received marketing authorisation from the UK...
Read more →

Pharma stock jumps after receiving approval from UK’s MHRA to sell new pharma product

(19 Jun 2025)
This small-cap pharma stock, engaged in the research, manufacturing, and marketing of generic pharmaceutical formulations across global...
Read more →

Marksans Pharma arm gets marketing authorization for Oxybutynin hydrochloride 2.5mg/5ml Oral Solution in...

(19 Jun 2025)
Mumbai: Marksans Pharma Limited, an Indian pharmaceutical company, has announced that its wholly owned subsidiary in the UK,...
Read more →

Marksans Pharma Share Price Today - Marksans Pharma Stock Price Live NSE/BSE

(18 Jun 2025)
Marksans Pharma Ltd. is a Public Limited Listed company incorporated on 16/04/1992 and has its registered office in the State of Maharashtra, India.
Read more →